Marine Bacterial Polysaccharide EPS11 Inhibits Cancer Cell Growth and Metastasis via Blocking Cell Adhesion and...

Area of Science:

• Marine biotechnology
• Cancer research
• Drug discovery

Background:

• Previous studies suggested EPS11, a marine bacterial polysaccharide, as a potential drug candidate for non-small cell lung carcinoma.
• This study investigates the anticancer mechanisms of EPS11 against liver cancer and its in vivo anti-metastatic effects.

Purpose of the Study:

• To elucidate the anticancer mechanisms of EPS11 against liver cancer cells.
• To evaluate the anti-metastatic potential of EPS11 in vivo.
• To identify potential molecular targets of EPS11.

Main Methods:

• Cytotoxicity assays on Huh7.5 liver cancer cells.
• Mass spectrometry-based proteomic analysis to identify protein expression changes.
• CD99 over-expression experiments to validate its role as a target.
• In vivo tumor nodule formation assay in a metastasis model.

Main Results:

• EPS11 inhibits liver cancer cell proliferation by blocking cell adhesion and destroying filiform structure formation.
• Proteomic analysis revealed significant changes in adhesion-related proteins, notably down-regulation of CD99.
• Over-expression of CD99 partially rescued EPS11-induced cell death and restored adhesion/migration.
• EPS11 administration significantly reduced lung tumor nodule formation, indicating in vivo anti-metastatic activity.

Conclusions:

• EPS11 inhibits liver cancer cell growth and metastasis through mechanisms involving CD99 down-regulation, disruption of cell adhesion, and filiform structure formation.
• EPS11 demonstrates significant potential as an anti-cancer therapeutic agent targeting metastasis.